Abdera Therapeutics

abderatx.com

Abdera Therapeutics Inc. is a precision oncology company focused on developing next-generation targeted radiation therapies. Utilizing a proprietary modular technology platform, the company aims to deliver radioisotopes that selectively destroy tumor cells while sparing healthy cells. Abdera is committed to rapidly developing therapies for cancer patients with limited treatment options, and is currently advancing its pipeline with plans to initiate a Phase 1 clinical trial for small cell lung cancer and large cell neuroendocrine carcinoma. With a strong team of experts in drug development and a focus on innovative cancer treatments, Abdera is positioned to make a significant impact in the oncology market.